CDC Treatment Evidence Review - consultation period

Discussion in '2021 USA CDC ME/CFS Diagnosis and Treatment Review' started by Medfeb, Jul 2, 2019.

  1. Ariel

    Ariel Senior Member (Voting Rights)

    Messages:
    1,065
    Location:
    UK
    Sorry if I'm missing something - why was the review done of bad evidence if the evidence was too low quality to base guidelines on it?
     
  2. Trish

    Trish Moderator Staff Member

    Messages:
    55,414
    Location:
    UK
    I guess because until someone has done a review for them laying out what research has been done, they don't know what the latest evidence is.
     
  3. Art Vandelay

    Art Vandelay Senior Member (Voting Rights)

    Messages:
    596
    Location:
    Adelaide, Australia
    Joh, Yessica, alktipping and 9 others like this.
  4. Simone

    Simone Senior Member (Voting Rights)

    Messages:
    452
    Location:
    Australia
    Thanks for sharing our submission. Unfortunately, we’ve had to resubmit because the references somehow disappeared when the document was formatted and I didn’t notice. *sigh*

    Hopefully the corrected document will be uploaded soon.
     
    alktipping, Joh, Simbindi and 7 others like this.
  5. Andy

    Andy Committee Member

    Messages:
    23,032
    Location:
    Hampshire, UK
    From a Solve email.

    "Solve M.E. evaluated if the report serves its purpose. We asked:

    1. Did the CDC accomplish the goal it published?
    2. Does this effort comply with Congressional intent?
    3. Did this effort contribute to the field?
    Our answers are: no, no, and no.

    Solve M.E. Public Comment Highlights:

    • Solve M.E. strongly recommends against the adoption of this review in any format
    • The review does not meet congressional intentions to “address medical misinformation and stigma,” “resolve case definition issues,” or “work with disease experts and patients”
    • Solve M.E. joins others who criticize the applicability of the findings, ineffectiveness of the review, failure to address harmful evidence, and failure to address bias
    • Solve M.E. encourages the utilization and incorporation of new data related to SARS-CoV-2 and Long COVID
    • CDC does not meet its own goals of publishing evidence-based treatment guidelines
    • Solve M.E. makes recommendations to improve patient input and raises concerns at the lack of transparency in selecting contractors and contractor’s review process
    Read our full comments on the review here."

    Also in same email.

    "In a recent public comment period, Solve M.E. criticized the CDC for failing to meet the guidance of Congress. A recent, potentially damaging, draft review took two years of CDC resources but doesn’t address any of the intentions published by Congress. Congress needs to know that CDC failing to meet its instructions to:

    • “collaborate with disease experts”
    • “resolve the case definition issues”
    • “counter medical misinformation and stigma”
    Send a message to your members of Congress today and ask them to ensure CDC is meeting its commitments to Congress and all Americans touched by ME/CFS.

    https://solvecfs.secure.force.com/actions/kwac__takeaction?actionId=AR00145 "
     
  6. NelliePledge

    NelliePledge Moderator Staff Member

    Messages:
    14,837
    Location:
    UK West Midlands
    Succinctly put by Solve.
     
    alktipping, Simbindi, Yessica and 4 others like this.
  7. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    9,920
    Location:
    UK
    didn't know where to post this but thought maybe someone in the US should suggest they update their website Last medically reviewed on July 18, 2017
    https://www.medicalnewstoday.com/articles/8877
     
    alktipping, Yessica, Joh and 6 others like this.
  8. Medfeb

    Medfeb Senior Member (Voting Rights)

    Messages:
    585
    At today's CDC stakeholder engagement call, Dr. Beth Unger made the following statement about the evidence review that they had contracted with a group (OSHU) in Oregon to conduct.

    Bottom line, neither they nor OSHU will be publishing the review in a peer reviewed journal. They will post it, comments, and responses on their web site.

    "As you likely remember, we undertook the systematic review as the first step in what we hoped would lead to the development of comprehensive ME/CFS treatment guidelines. We are committed to advancing the research and supporting the ME/CFS community however we can and recognize that improving clinical care remains a critical issue. However, after assessing the systematic review, we’ve decided that there is not enough evidence to move forward with treatment recommendations at this time. In the interest of transparency, we will be posting the final report, comments and responses on our ME/CFS website. We will not be publishing the systematic review in a peer reviewed journal. I want to note that, with the posting of the systematic review, we are not endorsing specific studies. But we do want the information to be available should others in the ME/CFS field undertake a review of the literature in the future."​
     
    mango, WillowJ, cfsandmore and 19 others like this.
  9. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    13,659
    Location:
    Canada
    OK so money and time wasted for nothing? That's just great leadership and management. It's just other people's money and lives, time's-a-wasting.

    Because it's always good news when someone screwed up and they tell you that it's all OK because they don't stand by what they did anyway. That's how you know this is in good capable leadership hands.
     
  10. Sean

    Sean Moderator Staff Member

    Messages:
    8,064
    Location:
    Australia
    At least they are not recommending crap 'treatments'. Sad when that is a step forward. But there it is.
     
    bobbler, mango, WillowJ and 6 others like this.
  11. Charles B.

    Charles B. Senior Member (Voting Rights)

    Messages:
    247
    I’m less buoyant than others regarding this measured CDC step. If the independent reviewer’s findings still find footing on the agency’s disease specific webpage, this may implicitly appear like a government endorsement of whatever drivel they cooked up.

    I can foresee some supercilious clinician citing it in a disingenuous fashion, especially considering the dearth of large systemic reviews of the existing ME literature. GET/CBT deserve to be consigned to the medical anti-canon. Anything that resurrects them in the slightest is despicable.

    N.B. I’m operating under the assumption that GET/CBT received a more effusive backing than the NICE Guidelines. I seem to recall discussion on how this Oregonian reviewer graded some GET/CBT studies more generously than merited. Happy to be disproven of course!
     
    livinglighter, bobbler, Ariel and 9 others like this.
  12. WillowJ

    WillowJ Senior Member (Voting Rights)

    Messages:
    676
    It would be nice if someone could arrange a conference so those at OHSU could meet and hear the doctors that are studying this disease in good ways. OHSU is very regionally influential, and could, if they wanted to and accessed the knowledge available, carry out research themselves.
     
    bobbler, Ariel, cfsandmore and 4 others like this.
  13. Three Chord Monty

    Three Chord Monty Senior Member (Voting Rights)

    Messages:
    212
    Hutan, ahimsa, Dolphin and 6 others like this.
  14. Hutan

    Hutan Moderator Staff Member

    Messages:
    29,374
    Location:
    Aotearoa New Zealand

Share This Page